The FUT8 gene, formally known as "fucosyltransferase 8," plays a crucial role in the glycosylation process. The gene is located on human chromosome 14 and is responsible for encoding a fucosyltransferase that catalyzes the transfer of fucose to the innermost N-acetylglucosamine (GlcNAc) residue of N-glycans via an α1,6-linkage. The core fucosylation process significantly affects the structural properties and functions of glycoproteins, which are essential for normal cellular functions such as cell signaling, cell adhesion, immune response, and protein stability.
Mutations or dysfunction of the FUT8 gene have been associated with various diseases and conditions. Abnormal glycosylation patterns due to up- or down-regulation of FUT8 activity can lead to abnormal cell signaling and disease progression. For example, reduced FUT8 activity is associated with developmental disorders such as congenital disorder of glycosylation (CDG IIc), while overexpression has been observed in several types of cancer, including liver, colorectal, and lung cancers, where it is thought to play a role in tumor progression and metastasis.
α1,6-fucosyltransferase (encoded by the FUT8 gene) is a key enzyme in mammalian cells that transfers fucose to the innermost GlcNAc residue of the N-glycan via α-1,6 linkages. The presence of core fucose on the Fc region of antibodies can inhibit antibody-dependent cellular cytotoxicity (ADCC) and reduce the therapeutic efficiency of antibodies in vivo. Chinese hamster ovary (CHO) cells are a major production platform for biopharmaceutical manufacturing. Therefore, it is advantageous to generate a FUT8 knockout (FUT8KO) CHO cell line that can be used to produce fully non-fucosylated antibodies.
To understand the role of FUT8 in CHO cell glycosylation, researchers performed a large-scale glycoproteomic study using the FUT8 knockout CHO cell line. A total of 7,127 unique intact glycopeptides (IGPs) containing N-linked glycosyl sites, 928 glycosyl sites, and 442 glycoproteins were identified from FUT8 knockout (FUT8KO) and WT CHO cells. In addition, 28.62% of 442 identified glycoproteins and 26.69% of 928 identified glycosylation sites were significantly changed in FUT8KO CHO compared with wild-type CHO cells. In addition, a decrease in fucosylation content was observed in FUT8KO cells, with the core fucosylated glycans almost disappearing, which was the effect of FUT8 knockout. Meanwhile, a total of 51 glycosylation-related enzymes were quantified in both cell types, 16 of which were significantly altered in FUT8KO cells. These glycoproteomic results revealed that the knockout of FUT8 not only affected the core fucosylation of proteins, but also altered other glycosylation synthesis processes and changed the relative abundance of protein glycosylation.
Figure 1. Changes in fucosylated glycoproteins in FUT8KO CHO cells. (A) Heat map of fucosylated and core-fucosylated glycoproteins in WT and FUT8KO CHO cells. (B) The percentage of core-fucosylated glycoproteins among fucosylated glycoproteins in WT and FUT8KO CHO cells. (C) Changes in fucosylation of protein CD166 (7 glycosites) in CHO cells with FUT8KO. (Yang G, et al., 2021)
The Fut8 gene encodes an enzyme called fucosyltransferase 8, which is involved in the core fucosylation of glycoproteins. The Fut8 gene was knocked out (KO) in the Chinese Hamster Ovary (CHO-K1) cell line in order to study the effects of the absence of this enzyme on glycoprotein function and production, particularly for therapeutic proteins. The following are the main applications of Fut8 KO CHO-K1 cells:
1. Glycoengineering and Biopharmaceutical Production
The Fut8 gene knockout in CHO-K1 cells plays an important role in glycoengineering aimed at producing glycoproteins with improved therapeutic properties. The absence of fucose residues on therapeutic proteins enhances antibody-dependent cellular cytotoxicity (ADCC), making these cells useful for the production of monoclonal antibodies with enhanced efficacy in cancer immunotherapy.
2. Glycosylation Studies
This cell line provides an excellent model for studying the role of fucosylation in protein function. Researchers can analyze the structural and functional effects of glycosylation on various proteins, helping to elucidate the mechanisms underlying diseases associated with glycosylation defects.
3. Cancer Research
Since aberrant fucosylation is associated with cancer progression and metastasis, Fut8 knockout CHO-K1 cells are used to study the role of fucose residues in tumor biology. This can lead to the discovery of new biomarkers and therapeutic targets for cancer treatment.
4. Vaccine Development
The altered glycosylation profiles of proteins expressed in Fut8 knockout CHO-K1 cells can be used for vaccine development. This approach aims to produce more immunogenic glycoproteins that elicit stronger immune responses.
Customer Q&As
How is the knockout cell line validated?
A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.
Is the product a single clonal cell or mixed cell pool?
A: Single clonal cell.
Can I confirm gene knockout by RT-qPCR?
A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.
How can I store the cell product?
A: The cell line should be stored in liquid nitrogen for long-term preservation.
Is it possible to get multiple knockout clones for my GOI?
A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.
Ask a Question
Customer Reviews
Worked very well
We have used the Fut8 Knockout Cell Line CHO-K1 in various assays, and the cells have consistently performed beyond our expectations.
The quality and consistency of the cells are outstanding.
The Fut8 Knockout CHO-K1 cells have proven to be incredibly useful for our glycoengineering projects. The quality and consistency of the cells are outstanding, and the knockout phenotype is stable even after multiple passages.
United Kingdom
01/03/2020
Write a Review